All

Abbott to Acquire Exact Sciences in $21 Billion Agreement

The deal positions Abbott to enter the US cancer screening and precision oncology diagnostics market with products including Cologuard and Oncotype DX tests.

All

Community Hospital Implements Abbott’s New Hematology Automation System

The hematology automation system aims to transform the capabilities of the hospital and facilitate the measurement of complete blood counts.

All

Randox Launches BNP Control to Diagnose Heart Failure

The BNP control is designed to be used alongside the Acusera range of third-party controls, providing a comprehensive package.

Quest Diagnostics Launches Consumer-Focused Rapid COVID Test with Observed Collection

Jan 28, 2022 | Covid 19, Immunoassay Reagents & test Kits

The new service features proctored telehealth by which a technician observes proper sample collection, confirms identity, and certifies results reporting.

Verichem Offers Liquid Stable Clinical Reference Mat’ls for Ethanol Testing

Dec 14, 2021 | Calibrators

Available from Verichem Laboratories are clinical reference materials intended for the calibration, or calibration verification, of ethanol assays.

Liquid Stable & Ready-to-Use Total Protein/Albumin Clinical Reference Materials Now Available

Nov 2, 2021 | Calibrators

Liquid stable and ready-to-use combined Total Protein/Albumin clinical reference materials are now available from Verichem Laboratories.

Toxicology Testing: Addressing the Epidemic within the Pandemic

Oct 22, 2021 | Immunoassay Reagents & test Kits, Specimen Collection & Handling, Urinalysis & Toxicology

Timely toxicology testing remains vital to patient treatment, but the challenge is staying ahead of emerging illicit drugs.

September 2021 Tech Guide: Point-of-Care Assays and Analyzers

Sep 20, 2021 | POC Instruments, POC Rapid Assays, POC Reagents & Test Kits

The Tech Guide from the September 2021 issue of Clinical Lab Products includes point-of-care assays and analyzers from 17 suppliers.

UPDATE: FDA Clarifies Abbott Alinity Kits’ Recall Is for Software, Details Fix

Sep 20, 2021 | Immunoassay Reagents & test Kits

The FDA has updated the Abbott Alinity Kits’ recall is for a software issue, which can be corrected with an update.

Abbott’s Covid-19 Antigen Test May Help with Faster Detection, Isolation, Per the CDC

Jan 26, 2021 | Covid 19, POC Rapid Assays

A study from the CDC found that BinaxNOW catches most infectious cases but may miss nearly two-thirds of covid-19 infections in people without symptoms.

HHS Continues Covid-19 Testing Support to States, High-Risk Groups

Dec 22, 2020 | Covid 19

HHS plans to provide weekly shipments of SARS-CoV-2 sample collection supplies to states and territories through at least March 2021.

New FDA Authorization for the BinaxNow Covid-19 Ag Card Home Test

Dec 16, 2020 | Covid 19, POC Rapid Assays

Abbott and eMed expect to deliver and administer 30 million BinaxNow tests in the first quarter of 2021, with an additional 90 million in the second quarter.

CE Mark for Abbott’s Covid-19 IgG Quantitative Antibody Test

Dec 16, 2020 | Covid 19, Immunoassay Reagents & test Kits

SARS-CoV-2 IgG II Quant antibody test specifically identifies levels of IgG antibodies that attach to the virus’ spike protein, which can be helpful to evaluate a person’s immune response to vaccines.